Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Fuselier T, Mota de Sa P, Qadir MMF, Xu B, Allard C, Meyers MM, et al
FDA-Noted Concerns: Increased heart rate Systemic vasodilatory reactions Limited clinical safety data Immunogenicity risk (antibody formation) Reported Side Effects: Injection site reactions (redness, swelling, itching) Headache Flushing Dizziness Nausea Water retention Serious Concerns: Potential for glucose metabolism disruption Theoretical cancer risk (GH/IGF-1 promote cell proliferation) Long-term safety unknown Regulatory Status United States: CJC-1295 is not FDA approved for any indication
Administering your injection in the morning rather than the evening helps avoid nausea and GI discomfort at night, improving your sleep quality
Nanomed: Nanotechnol Biol Med (2017) 13:65965
US$ 25.88
US$ 25.83
US$ 22.64
US$ 26.46
US$ 21.62
US$ 28.01
US$ 29.40
